BREXOGEN Inc.
PrivateLast Round
Series C
Sep 1, 2023
Total Funding Raised
$25.82M
Company Overview
BREXOGEN Inc. is a biotechnology company that develops cell-free regenerative medicines using its proprietary stem cell-derived exosome platform technology to target incurable diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BREXOGEN Inc. Comparables
Compare BREXOGEN Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ExoStemTech | 87% | |
| ILIAS Biologics Inc. | 87% | |
| EXORPHIA Inc. | 84% |
BREXOGEN Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Sep 1, 2023 | ||||
| Series B | Dec 1, 2021 | ||||
| Series A | Sep 21, 2020 | ||||
| Pre Seed | Oct 1, 2019 |
BREXOGEN Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UTC Investment | Series B, Series C, Series A |
| Korea Investment Partners | Series B, Series C, Series A |
| Timefolio Asset Management | Series B, Series C, Pre Seed, Series A |
| Stonebridge Ventures | Series A |
| KB Securities | Series B, Series A |
| Korea Development Bank | Series B, Series C |
| Korea Venture Investment Corporation | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 1, 2023
$9M round with participation from Timefolio Asset Management and UTC Investment.
- Oct 1, 2019
$2.1M round from Tigris Investment and Timefolio Asset Management.
BREXOGEN Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about BREXOGEN Inc.'s valuation, stock price, and market status.
Is BREXOGEN Inc. a public or private company?
BREXOGEN Inc. is a private company.
What is the current stock price of BREXOGEN Inc.?
BREXOGEN Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is BREXOGEN Inc. worth (valuation)?
Valuation information for BREXOGEN Inc. is not publicly available.
Can I buy BREXOGEN Inc. stock?
BREXOGEN Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was BREXOGEN Inc.'s last funding round?
BREXOGEN Inc.'s most recent funding round was Series C on September 1, 2023.
Who are the main investors in BREXOGEN Inc.?
Key investors in BREXOGEN Inc. include Korea Investment Partners.
Will BREXOGEN Inc. IPO soon?
No public IPO plans have been announced for BREXOGEN Inc..
How can I track BREXOGEN Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BREXOGEN Inc.'s secondary market activity and sign up for updates.